Browse > Article

Increased osteopontin expression in activated glial cells in experimental autoimmune encephalomyelitis  

Park, Suk-jae (Department of Veterinary Medicine and Applied Radiological Science Institute, College of Applied Life Science, Cheju National University)
Hwang, In-sun (Department of Veterinary Medicine and Applied Radiological Science Institute, College of Applied Life Science, Cheju National University)
Kim, Gyu-beom (Department of Veterinary Medicine and Applied Radiological Science Institute, College of Applied Life Science, Cheju National University)
Shin, Tae-kyun (Department of Veterinary Medicine and Applied Radiological Science Institute, College of Applied Life Science, Cheju National University)
Jee, Young-heun (Department of Veterinary Medicine and Applied Radiological Science Institute, College of Applied Life Science, Cheju National University)
Publication Information
Korean Journal of Veterinary Research / v.46, no.3, 2006 , pp. 177-184 More about this Journal
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a disease model of multiple sclerosis (MS) that is characterized by remittance and relapse of the disease and autoimmune and demyelinating lesions in the central nervous system (CNS). Autoimmune inflammation is maintained by secretion of a large number of protein. Previous studies have suggested that transcripts encoding osteopontin (OPN) are frequently detected in the mRNA population of MS plaques. To elucidate the functional role of OPN in initiation and development of EAE, we examined the expression and localization of OPN in the spinal cord during acute EAE. We demonstrated that OPN significantly increased at the early stage of EAE and slightly declined thereafter by western blot analysis. An immunohistochemical study revealed that OPN was constitutively expressed in some glial cells (microglia, astrocytes) of white matter and neurons in the CNS of control rats. OPN expression was shown to be increased in the same cells at the early and peak stage of EAE. To identity cells expressing OPN by double-immunofluorescence labeling, we labeled rat spinal cord sections for OPN with a monoclonal OPN antibody and with mAbs for astrocyte (GFAP), microglia/macrophage (OX42)-specific markers. The major cell types of OPN-expressing cells were activated astrocytes and microglia in the adjacent inflammatory lesions. Interestingly, OPN was mainly expressed in the end feet of astrocytes around vascular cell adhesion molecule-1 (VCAM-1) expressing endothelial cells of CNS blood vessel. These findings suggest that increased levels of OPN in activated glial cell may play an important role in the recruitment of inflammatory cells into the CNS parenchyma during EAE.
Keywords
experimental autoimmune encephalomyelitis (EAE); osteopontin (OPN); activated asσocyte; glial cell;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Damle NK, Aruffo A. Vascular cell adhesion molecule I induces T-cell antigen receptor-dependent activation of CD4q T lymphocytes. Proc Natl Acad Sci 1991, 88, 6403-6407
2 Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachell CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 1995, 95, 713-724   DOI   ScienceOn
3 Melanie Laschinger, Britta Engelhardt. Interaction of ${\alpha}4-integrin$ with VCAM-I is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J Neuroimmunol 2000, 102, 32-43   DOI   ScienceOn
4 Raine CS. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997, 77, 135-152   DOI   ScienceOn
5 Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-l and VCAM-l in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994, 145(1), 189-201
6 Ashkar S, Weber GF, Panoutsakopoulou V. Etal (osteopontin): an early component of type-l (cell-mediated) immunity. Science 2000, 287, 860-864   DOI   ScienceOn
7 Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice PA, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW. A controlled trial of natalizumab for relapsing multiple sclerosis. New Engl J Med 2003, 348, 15-23   DOI   ScienceOn
8 Chabas D, Baranzini SE, Mitchell D. The influence of the proinflammatory cytokine,osteopontin, on autoimmune demyelinating disease. Science 2001, 294, 1731-1735   DOI   ScienceOn
9 Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995, 45, 16-21   DOI
10 Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995, 37, 424-435   DOI   ScienceOn
11 Bayless KJ, Meininger GA, Scholtz JM, Davis GE. Osteopontin is a ligand for the a4bl integrin. J Cell Sci 1998, 111, 1165-1174
12 Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19, 331-338   DOI   ScienceOn
13 Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76, 301-314   DOI   ScienceOn
14 Lee SJ, Benveniste EN. Adhesion molecule expression and regulation on cell of central nervous system. J Neuroimmunol 1999, 98, 77-88   DOI   ScienceOn
15 Raine CS, Traugott U. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis. Ann N Y Acad Sci 1984, 436, 33-51   DOI
16 Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR. VCAM-I on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 1990, 60, 577-584   DOI   ScienceOn
17 O'Connor KC, Bar-Or A, Hafler DA. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol 2001, 21, 81-92   DOI   ScienceOn
18 Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992, 356, 63-66   DOI   ScienceOn
19 Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994, 74, 214-224   DOI   ScienceOn
20 Matsumoto Y, Ohmori K, Fujiwara M. Microglial and astroglial reaction to inflammatory lesions of experimental autoimmune encephlomyelitis in the rat central nervous system. J Neuroimmunol 1992, 37, 23-33   DOI   ScienceOn
21 Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr. Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993, 177, 57-68   DOI
22 Nemir M, DeVouge MW, Mukherjee BB. Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J Biol Chem 1998, 264, 18202-18208
23 Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1986, 83, 8819-8823
24 Bayless KJ, Davis GE. Identification of dual alpha 4 beta I integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J Biol Chem 2001, 276, 13483-13489   DOI   ScienceOn
25 Chellaiah MA, Hruska KA. The integrin alpha (v) beta (3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue 2003, 72, 197-205   DOI
26 Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 2001, 36, 249-257   DOI   ScienceOn